BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access Research article

Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients

Trevor J Pugh1†, Gwyn Bebb2†, Lorena Barclay3, Margaret Sutcliffe3, John Fee3, Chris Salski4, Robert O'Connor4, Cheryl Ho5, Nevin Murray5, Barbara Melosky5, John English6, Jeurgen Vielkind3, Doug Horsman4, Janessa J Laskin5 and Marco A Marra1*

  • * Corresponding author: Marco A Marra mmarra@bcgsc.ca

  • † Equal contributors

Author Affiliations

1 Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

2 Tom Baker Cancer Centre, Calgary, BC, Canada

3 Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, Canada

4 Department of Pathology, BC Cancer Agency, Vancouver, Canada

5 Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada

6 Department of Pathology and Laboratory Medicine, Vancouver Hospital, Vancouver, Canada

For all author emails, please log on.

BMC Cancer 2007, 7:128 doi:10.1186/1471-2407-7-128

Published: 13 July 2007

Additional files

Additional file 1:

Supplemental Table 1 – Summary of all patient clinical data and molecular status. A table containing clinical data and molecular status of all patients studied.

Format: DOC Size: 118KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data